QTI QT IMAGING HOLDINGS, INC.
Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1844505 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY220.0%
TTM net income YoY8.2%
TTM EPS YoY58.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin40.4%
Operating margin-24.8%
Net margin-77.3%
FCF margin-48.2%
EBITDA margin-24.5%
Returns
ROE-2,125.0%
ROA-96.6%
ROIC (approx.)-98.7%
Asset turnover1.25x
Leverage & solvency
Liabilities / assets92.7%
Debt / equity5.07x
Current ratio3.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.61x
Accruals ratio-37.6%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $18.93M | $4.88M | $40,355 | $0 | — |
| Cost of revenue | $10.34M | $2.24M | $134,988 | — | — |
| Gross profit | $8.58M | $2.64M | -$94,633 | — | — |
| R&D expense | $3.94M | $3.27M | $1.49M | — | — |
| SG&A expense | $9.09M | $11.55M | $3.43M | $4.28M | $1.08M |
| Operating income | -$4.44M | -$12.18M | -$5.01M | -$4.28M | -$1.08M |
| Interest expense | — | — | $219,686 | $23,098 | — |
| Pretax income | -$21.08M | -$9.00M | -$6.10M | -$2.29M | -$1.11M |
| Income tax | -$1,000 | -$16,000 | $1,600 | $486,615 | $1,783 |
| Net income | -$21.08M | -$8.98M | -$6.10M | -$2.77M | -$1.11M |
| EBITDA | -$4.31M | -$11.95M | -$4.53M | — | — |
| EPS (basic) | -2.01 | -2.13 | -0.64 | -0.60 | -0.14 |
| EPS (diluted) | -2.01 | -2.13 | -0.64 | -0.60 | -0.14 |
| Weighted avg. shares (diluted) | 10.48M | 6.66M | 9.54M | 6.54M | 8.19M |
| Balance sheet | |||||
| Cash & equivalents | $10.41M | $1.17M | $184,686 | $475,076 | $421,549 |
| Receivables | $5.78M | $67,000 | $1,290 | — | — |
| Inventory | $5.03M | $3.14M | $4.42M | — | — |
| Current assets | $22.09M | $4.92M | $4.82M | $250,704 | $1.16M |
| PP&E, net | $318,000 | $196,000 | $490,920 | — | — |
| Total assets | $23.02M | $6.09M | $6.71M | $41.95M | $233.63M |
| Current liabilities | $7.87M | $9.79M | $7.34M | $4.19M | $633,641 |
| Long-term debt | $10.11M | $9.93M | — | — | — |
| Total debt | $10.11M | $9.93M | — | — | — |
| Total liabilities | $16.58M | $15.62M | $12.02M | $13.42M | $10.25M |
| Shareholders' equity | $6.45M | -$9.54M | -$5.31M | -$1.51M | -$8.92M |
| Net debt | -$303,000 | $8.76M | — | — | — |
| Shares outstanding | 11.90M | 8.93M | 9.58M | 6.54M | 6.54M |
| Cash flow statement | |||||
| Operating cash flow | -$8.96M | -$10.03M | -$2.65M | -$1.26M | -$1.37M |
| Capital expenditure | $124,000 | $88,000 | $13,040 | — | — |
| Free cash flow | -$9.08M | -$10.12M | -$2.66M | — | — |
| Investing cash flow | -$124,000 | -$88,000 | -$13,040 | $192.24M | -$232.30M |
| Financing cash flow | $18.35M | $11.13M | $2.37M | -$191.32M | $234.09M |
| Depreciation & amortization | $131,000 | $231,000 | $480,694 | — | — |
| Stock-based compensation | $801,000 | $290,000 | $709,394 | — | $95,200 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.